{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:26:08Z","timestamp":1770996368656,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.micpath.2004.10.007","type":"journal-article","created":{"date-parts":[[2004,12,22]],"date-time":"2004-12-22T01:35:48Z","timestamp":1103679348000},"page":"33-40","source":"Crossref","is-referenced-by-count":33,"title":["Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain"],"prefix":"10.1016","volume":"38","author":[{"given":"H.C.","family":"Flick-Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.L.","family":"Waters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Stagg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.D.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2004.10.007_bib1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0264-410X(97)00268-5","article-title":"Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers","volume":"16","author":"McBride","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2004.10.007_bib2","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.282.22.2104","article-title":"Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax","volume":"282","author":"Friedlander","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.micpath.2004.10.007_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/IAI.49.2.291-297.1985","article-title":"Demonstration of a capsule plasmid in Bacillus anthracis","volume":"49","author":"Green","year":"1985","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2004.10.007_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/IAI.39.1.371-376.1983","article-title":"Evidence for plasmid mediated toxin production in Bacillus anthracis","volume":"39","author":"Mikesell","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2004.10.007_bib5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2004.10.007_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1099\/00221287-138-3-543","article-title":"Serum protease cleavage of Bacillus anthracis protective antigen","volume":"138","author":"Ezzell","year":"1992","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.micpath.2004.10.007_bib7","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","article-title":"A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2004.10.007_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/IAI.51.3.795-800.1986","article-title":"Differences in susceptibility of inbred mice to Bacillus anthracis","volume":"51","author":"Welkos","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2004.10.007_bib9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1128\/IAI.45.3.761-767.1984","article-title":"Immunoelectrophoretic analysis, toxicity and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin","volume":"45","author":"Ezzell","year":"1984","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2004.10.007_bib10","first-page":"123","article-title":"Efficacy of the UK human anthrax vaccine in guinea pig against aerosolised spores of Bacillus anthracis","volume":"87","author":"Jones","year":"1985","journal-title":"Salisbury Med Bull"},{"key":"10.1016\/j.micpath.2004.10.007_bib11","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin","volume":"19","author":"Fellows","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2004.10.007_bib12","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2004.10.007_bib13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2004.10.007_bib14","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume":"16","author":"Ivins","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2004.10.007_bib15","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0264-410X(96)00277-0","article-title":"Non-human primate models to evaluate vaccine safety and immunogenicity","volume":"15","author":"Kennedy","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2004.10.007_bib16","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1128\/CDLI.6.6.953-958.1999","article-title":"Comparison and characterisation of immunoglobulin G subclasses among primate species","volume":"6","author":"Shearer","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.micpath.2004.10.007_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0882-4010(88)90015-0","article-title":"Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice","volume":"5","author":"Welkos","year":"1988","journal-title":"Microb Pathogen"},{"key":"10.1016\/j.micpath.2004.10.007_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2672.1999.00901.x","article-title":"Presentation of protective antigen to the mouse immune system: immune sequelae","volume":"87","author":"Williamson","year":"1999","journal-title":"J Appl Micro"},{"key":"10.1016\/j.micpath.2004.10.007_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1365-2567.1998.00423.x","article-title":"Low antigen dose favours selection of somatic mutants with hallmarks of antibody affinity maturation","volume":"93","author":"Gonzalez-Fernandez","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.micpath.2004.10.007_bib20","doi-asserted-by":"crossref","first-page":"52425","DOI":"10.1074\/jbc.M309034200","article-title":"Differential processing of CD4 T-cell epitopes from the protective antigen of Bacillus anthracis","volume":"278","author":"Musson","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.micpath.2004.10.007_bib21","first-page":"49","article-title":"Pathogenesis and host resistance to Bacillus anthracis: a mouse model","author":"Welkos","year":"1990"},{"key":"10.1016\/j.micpath.2004.10.007_bib22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/IAI.60.2.662-668.1992","article-title":"Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants","volume":"60","author":"Ivins","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2004.10.007_bib23","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.vaccine.2003.12.027","article-title":"Development of an in vitro-based potency assay for anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2004.10.007_bib24","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1016\/S0264-410X(01)00197-9","article-title":"Passive transfer of protection against Bacillus anthracis infection in a murine model","volume":"19","author":"Beedham","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2004.10.007_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1472-765X.1998.00274.x","article-title":"Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracis","volume":"26","author":"Miller","year":"1998","journal-title":"Lett Appl Micro"},{"key":"10.1016\/j.micpath.2004.10.007_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1017\/S0022172400019422","article-title":"An apparatus for the study of airbourne infection","volume":"50","author":"Henderson","year":"1952","journal-title":"J Hygiene, Cambridge"},{"key":"10.1016\/j.micpath.2004.10.007_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0021-8502(73)90006-2","article-title":"The collison nebulizer: description, performance and application","volume":"4","author":"May","year":"1973","journal-title":"J Aero Sci"},{"key":"10.1016\/j.micpath.2004.10.007_bib28","series-title":"A primer of biostatistics","author":"Glantz","year":"1997"},{"key":"10.1016\/j.micpath.2004.10.007_bib29","series-title":"Medical statistics at a glance","author":"Petrie","year":"2000"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401004001500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401004001500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T21:40:30Z","timestamp":1586036430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401004001500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0882401004001500"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2004.10.007","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}